Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
JP Stock MarketDetailed Quotes
145A L is B
- 628
- -7-1.10%
20min DelayMarket Closed Jan 9 15:30 JST
3.22BMarket Cap67.57P/E (Static)
635High626Low16.50KVolume629Open635Pre Close10.39MTurnover169052wk High1.79%Turnover Ratio5.12MShares60552wk Low9.294EPS TTM579.83MFloat Cap1690Historical High67.57P/E (Static)923.30KShs Float605Historical Low9.294EPS LYR1.42%Amplitude--Dividend TTM1.89P/B100Lot Size--Div YieldTTM
L is B Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|
| Operating cash flow (Indirect Method) | |||
| Cash from operating activities | 99.92%-125K | 68.05%-149.85M | -469.02M |
| Net profit before non-cash adjustment | 110.35%32.15M | 5.87%-310.62M | ---329.99M |
| Total adjustment of non-cash items | -71.61%13.57M | 126.65%47.8M | --21.09M |
| -Depreciation and amortization | 1,079.76%6.94M | -76.70%588K | --2.52M |
| -Reversal of impairment losses recognized in profit and loss | --0 | 163.37%44.75M | --16.99M |
| -Assets reserve and write-off | ---- | ---- | --273K |
| -Other non-cash items | 169.02%6.63M | 89.26%2.47M | --1.3M |
| Changes in working capital | -140.58%-45.84M | 170.55%112.97M | ---160.12M |
| -Change in receivables | -217.35%-49.39M | 133.37%42.09M | ---126.14M |
| -Change in inventory | -425.00%-689K | 169.97%212K | ---303K |
| -Change in payables | -118.36%-10.29M | 1,292.07%56.05M | ---4.7M |
| -Change in accrued expense | ---- | ---- | ---16.39M |
| -Provision for loans, leases and other losses | 108.71%27K | ---310K | ---- |
| -Changes in other current assets | 483.72%15.7M | 121.36%2.69M | ---12.59M |
| -Changes in other current liabilities | -109.80%-1.2M | --12.24M | ---- |
| Dividends paid (cash flow from operating activities) | |||
| Dividends received (cash flow from operating activities) | |||
| Interest paid (cash flow from operating activities) | -216.81%-6.09M | -144.84%-1.92M | -785K |
| Interest received (cash flow from operating activities) | -10.00%9K | 66.67%10K | 6K |
| Tax refund paid | 0.02%-5.87M | -514.12%-5.87M | -956K |
| Other operating cash inflow (outflow) | 0 | 0 | -1K |
| Operating cash flow | 92.34%-12.08M | 66.52%-157.63M | ---470.76M |
| Investing cash flow | |||
| Net PPE purchase and sale | -59.05%-6.3M | 65.90%-3.96M | ---11.62M |
| Net intangibles purchase and sale | 21.77%-38.38M | -521.06%-49.06M | ---7.9M |
| Net changes in other investments | ---4.46M | ---- | ---621K |
| Investing cash flow | 7.33%-49.14M | -163.32%-53.03M | ---20.14M |
| Financing cash flow | |||
| Net issuance payments of debt | -108.00%-17.51M | -2.42%218.74M | --224.16M |
| Net common stock issuance | ---- | ---- | --1B |
| Financing cash flow | -108.00%-17.51M | -82.14%218.74M | --1.23B |
| Net cash flow | |||
| Beginning cash position | 0.75%1.09B | 212.05%1.08B | --346.23M |
| Current changes in cash | -1,073.44%-78.72M | -98.90%8.09M | --734.19M |
| Cash adjustments other than cash changes | 0.00%-1K | 0.00%-1K | ---1K |
| End cash Position | -7.23%1.01B | 0.75%1.09B | --1.08B |
| Free cash flow | 73.06%-56.76M | 57.03%-210.66M | ---490.28M |
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion |